Potential Seen for Tailoring Acute Myeloid Leukemia Treatment

December 3, 2018 | Categories: Announcements, Research | Tagged: , ,

Drug response screening of leukemia stem cells offers clues to relapse and suggests ways to improve patient-specific therapies Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia (AML). Research on the drug responses of leukemia stem cells may reveal why some […] Read More

Study: Using big data to help fight a deadly cancer

January 12, 2018 | Categories: Research | Tagged: , ,

Researchers built an algorithm to discern which drugs might best combat patients’ individual cases of acute myeloid leukemia. The statistics are grim. For patients fighting an aggressive form of leukemia known as acute myeloid leukemia, or AML, doctors over the last 40 years have usually used a combination of two drugs to fight the disease, but it seldom cures it. Read More

Drs. Pam Becker

Congratulations to Faculty Award Winner Pam Becker, MD, PhD

July 10, 2015 | Categories: Announcements | Tagged: ,

Congratulations to ISCRM’s Pam Becker, who was selected as the 2015 Faculty Award winner by the graduating Hematology/Oncology fellows at the annual fellow’s graduation ceremony that took place Monday, June 29th. The award honors a faculty member for their dedication to fellow’s education, as well as patient care and research.  Pam is heavily involved in […] Read More